The future of vaccine administration my change forever with Pharmajet's needle-free injector

FDA Approves AFLURIA Flu Vaccine To Be Administered With Pharmajet’s Needle-Free Injector

The future of vaccine administration my change forever with Pharmajet’s needle-free injector The FDA has approved the first needle-free drug system for the delivery of bioCSL’s influenza vaccine AFLURIA. Now, doctors and other health care workers can chose whether they want to administer the influenza vaccine via a needle or through PharmaJet’s needle-free system. Ron Lowy, the CEO of PharmaJet, …

bioCSL Inc. Launches AFLURIA Shipping Campaign for 2014-2015 Seasonal Influenza

August 5th, 2014 bioCSL Inc. to supply U.S. Market with 16.5 Million Doses Historical reliability, coupled with dedicated commercial and production efforts, drive strong customer prebook order demand Early season deliveries will support U.S. providers’ 2014-15 vaccination needs bioCSL Inc. announced today it has commenced shipping its seasonal influenza vaccine AFLURIA(Influenza Vaccine) for the 2014-2015 flu season. U.S. providers who ordered AFLURIA may …

bioCSL supports public health efforts in Laos with donation of more than 700,000 doses of seasonal influenza vaccine

Participation in innovative public-private collaboration helps improve vaccination infrastructure, expand patient reach in partner countries April 28, 2014 bioCSL, formerly CSL Biotherapies, has announced the donation of more than 700,000 doses of its influenza vaccine to the Partnership for Influenza Vaccine Introduction, an innovative program – spearheaded by the U.S. Centers for Disease Control and Prevention (CDC) and the Task Force …